Stroke-induced immunodepression and post-stroke infections: Lessons from the preventive antibacterial therapy in stroke trial

Neuroscience

Volumn 158, Issue 3, 2009, Pages 1184-1193

  Klehmet, J ^a   Harms, H ^a   Richter, M ^a   Prass, K ^b   Volk, H D ^a   Dirnagl, U ^a   Meisel, A ^a   Meisel, C ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b Landesklinikum Waldviertel Horn ^*  (Austria)

Author keywords

cytokines; infection; lymphocytes; stroke; stroke induced immunodepression

Indexed keywords

CEFTAZIDIME; CIPROFLOXACIN; GAMMA INTERFERON; HYDROCORTISONE; INTERLEUKIN 10; INTERLEUKIN 6; MOXIFLOXACIN; NORADRENALIN; PLACEBO; RIBOFLAVIN; TOBRAMYCIN;

ACUTE DISEASE; ADULT; ANTIMICROBIAL THERAPY; ARTICLE; CD4+ T LYMPHOCYTE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE ASSOCIATION; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HYDROCORTISONE BLOOD LEVEL; HYDROCORTISONE URINE LEVEL; IMMUNE DEFICIENCY; IMMUNE RESPONSE; IMMUNOPATHOGENESIS; INFECTION; INFECTION PREVENTION; INFECTION RISK; LONGITUDINAL STUDY; LYMPHOCYTOPENIA; MAJOR CLINICAL STUDY; MULTICENTER STUDY; NORADRENALIN URINE LEVEL; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; SHORT COURSE THERAPY; STROKE; STROKE PATIENT; T LYMPHOCYTE SUBPOPULATION;

ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; DOUBLE-BLIND METHOD; FEMALE; FLOW CYTOMETRY; HUMANS; HYDROCORTISONE; IMMUNE TOLERANCE; IMMUNITY, CELLULAR; IMMUNOCOMPROMISED HOST; INTERFERON-GAMMA; INTERLEUKINS; LYMPHOCYTE COUNT; LYMPHOPENIA; MALE; NOREPINEPHRINE; PLACEBO EFFECT; STROKE;

EID: 59349092158     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2008.07.044     Document Type: Article

References (30)

1. Bartlett J.G., Dowell S.F., Mandell L.A., File Jr. T.M., Musher D.M., and Fine M.J. Practice guidelines for the management of community-acquired pneumonia in adults. Infectious Diseases Society of America. Clin Infect Dis 31 (2000) 347-382
2. Beamer N.B., Coull B.M., Clark W.M., Hazel J.S., and Silberger J.R. Interleukin-6 and interleukin-1 receptor antagonist in acute stroke. Ann Neurol 37 (1995) 800-805
3. Braun J.S., Prass K., Dirnagl U., Meisel A., and Meisel C. Protection from brain damage and bacterial infection in murine stroke by the novel caspase-inhibitor Q-VD-OPH. Exp Neurol 206 (2007) 183-191
4. Chamorro A., Amaro S., Vargas M., Obach V., Cervera A., Gomez-Choco M., Torres F., and Planas A.M. Catecholamines, infection, and death in acute ischemic stroke. J Neurol Sci 252 (2007) 29-35
5. Chamorro A., Amaro S., Vargas M., Obach V., Cervera A., Torres F., and Planas A.M. Interleukin 10, monocytes and increased risk of early infection in ischaemic stroke. J Neurol Neurosurg Psychiatry 77 (2006) 1279-1281
6. Dalhoff A., and Shalit I. Immunomodulatory effects of quinolones. Lancet Infect Dis 3 (2003) 359-371
7. Davenport R.J., Dennis M.S., Wellwood I., and Warlow C.P. Complications after acute stroke. Stroke 27 (1996) 415-420
8. Dirnagl U., Klehmet J., Braun J.S., Harms H., Meisel C., Ziemssen T., Prass K., and Meisel A. Stroke-induced immunodepression: experimental evidence and clinical relevance. Stroke 38 (2007) 770-773
9. Dziedzic T., Slowik A., Pera J., and Szczudlik A. Beta-blockers reduce the risk of early death in ischemic stroke. J Neurol Sci 252 (2007) 53-56
10. Elenkov I.J., Wilder R.L., Chrousos G.P., and Vizi E.S. The sympathetic nerve-an integrative interface between two supersystems: the brain and the immune system. Pharmacol Rev 52 (2000) 595-638
11. Emsley H.C., Smith C.J., Gavin C.M., Georgiou R.F., Vail A., Barberan E.M., Hallenbeck J.M., del Zoppo G.J., Rothwell N.J., Tyrrell P.J., and Hopkins S.J. An early and sustained peripheral inflammatory response in acute ischaemic stroke: relationships with infection and atherosclerosis. J Neuroimmunol 139 (2003) 93-101
12. Haeusler K.G., Schmidt W.U., Fohring F., Meisel C., Helms T., Jungehulsing G.J., Nolte C.H., Schmolke K., Wegner B., Meisel A., Dirnagl U., Villringer A., and Volk H.D. Cellular immunodepression preceding infectious complications after acute ischemic stroke in humans. Cerebrovasc Dis 25 (2008) 50-58
13. Harms H., Prass K., Meisel C., Klehmet J., Rogge W., Drenckhahn C., Göhler J., Bereswill S., Wernecke K., Wolf T., Arnold G., Halle E., Volk H.D., Dirnagl U., and Meisel A. Preventive antibacterial therapy in acute ischemic stroke: a randomized controlled trial. PloSOne 3 5 (2008) e2158
14. Johnston K.C., Li J.Y., Lyden P.D., Hanson S.K., Feasby T.E., Adams R.J., Faught Jr. R.E., and Haley Jr. E.C. Medical and neurological complications of ischemic stroke: experience from the RANTTAS trial. RANTTAS Investigators. Stroke 29 (1998) 447-453
15. Katzan I.L., Dawson N.V., Thomas C.L., Votruba M.E., and Cebul R.D. The cost of pneumonia after acute stroke. Neurology 68 (2007) 1938-1943
16. Langhorne P., Stott D.J., Robertson L., MacDonald J., Jones L., McAlpine C., Dick F., Taylor G.S., and Murray G. Medical complications after stroke: Multicenter study. Stroke 31 (2000) 1223-1229
17. Lode H. Evidence of different profiles of side effects and drug-drug interactions among the quinolones: the pharmacokinetic standpoint. Chemotherapy 47 Suppl 3 (2001) 24-31 discussion 44-48
18. Lucin K.M., Sanders V.M., Jones T.B., Malarkey W.B., and Popovich P.G. Impaired antibody synthesis after spinal cord injury is level dependent and is due to sympathetic nervous system dysregulation. Exp Neurol 207 (2007) 75-84
19. Meisel C., Prass K., Braun J., Victorov I., Wolf T., Megow D., Halle E., Volk H.D., Dirnagl U., and Meisel A. Preventive antibacterial treatment improves the general medical and neurological outcome in a mouse model of stroke. Stroke 35 (2004) 2-6
20. Meisel C., Schwab J.M., Prass K., Meisel A., and Dirnagl U. Central nervous system injury-induced immune deficiency syndrome. Nat Rev Neurosci 6 (2005) 775-786
21. Offner H., Subramanian S., Parker S.M., Wang C., Afentoulis M.E., Lewis A., Vandenbark A.A., and Hurn P.D. Splenic atrophy in experimental stroke is accompanied by increased regulatory T cells and circulating macrophages. J Immunol 176 (2006) 6523-6531
22. Prass K., Braun J.S., Dirnagl U., Meisel C., and Meisel A. Stroke propagates bacterial aspiration to pneumonia in a model of cerebral ischemia. Stroke 37 (2006) 2607-2612
23. Prass K., Meisel C., Hoflich C., Braun J., Halle E., Wolf T., Ruscher K., Victorov I.V., Priller J., Dirnagl U., Volk H.D., and Meisel A. Stroke-induced immunodeficiency promotes spontaneous bacterial infections and is mediated by sympathetic activation reversal by poststroke T helper cell type 1-like immunostimulation. J Exp Med 198 (2003) 725-736
24. Riegger T., Conrad S., Liu K., Schluesener H.J., Adibzahdeh M., and Schwab J.M. Spinal cord injury-induced immune depression syndrome (SCI-IDS). Eur J Neurosci 25 (2007) 1743-1747
25. Smith C.J., Emsley H.C., Gavin C.M., Georgiou R.F., Vail A., Barberan E.M., del Zoppo G.J., Hallenbeck J.M., Rothwell N.J., Hopkins S.J., and Tyrrell P.J. Peak plasma interleukin-6 and other peripheral markers of inflammation in the first week of ischaemic stroke correlate with brain infarct volume, stroke severity and long-term outcome. BMC Neurol 4 (2004) 2
26. Toni D., Chamorro A., Kaste M., Lees K., Wahlgren N.G., and Hacke W. Acute treatment of ischaemic stroke. European Stroke Initiative. Cerebrovasc Dis 17 Suppl 2 (2004) 30-46
27. Vila N., Castillo J., Davalos A., and Chamorro A. Proinflammatory cytokines and early neurological worsening in ischemic stroke. Stroke 31 (2000) 2325-2329
28. Vogelgesang A., Grunwald U., Langner S., Jack R., Broker B.M., Kessler C., and Dressel A. Analysis of lymphocyte subsets in patients with stroke and their influence on infection after stroke. Stroke 39 (2008) 237-241
29. Walter U., Knoblich R., Steinhagen V., Donat M., Benecke R., and Kloth A. Predictors of pneumonia in acute stroke patients admitted to a neurological intensive care unit. J Neurol 254 (2007) 1323-1329
30. Woiciechowsky C., Asadullah K., Nestler D., Eberhardt B., Platzer C., Schoning B., Glockner F., Lanksch W.R., Volk H.D., and Docke W.D. Sympathetic activation triggers systemic interleukin-10 release in immunodepression induced by brain injury. Nat Med 4 (1998) 808-813